Eli Lilly ' s weight loss drug reduces sleep apnea, study shows

Eli Lilly's weight loss-related drug Zepbound could potentially be used to reduce the severity of sleep apnea in adults with obesity, according to a recent study. Results of a phase three clinical trial, published Wednesday, showed that injections of the drug, either 10 mg or 15 mg, "significantly…#elililly #specificallylilly #zepbound #lilly #jeffemmick #wegovy #fda #novonordisk
Source: Reuters: Health - Category: Consumer Health News Source Type: news